Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Strata Oncology

Strata Oncology
2015 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Series B LATEST DEAL TYPE
$26M LATEST DEAL AMOUNT
8 INVESTORS
Description

Provider of precision oncology testing and patient matching services for drug testing trials intended to expand patient access to tumor sequencing and precision medicine trials. The company shortens clinical development timelines by proactively matching genotyped patients to industry-sponsored clinical trials for the most promising precision medicines and bringing together a collaborative network of leading cancer hospitals, helping pharma and healthcare providers to accelerate precision medicine for cancer patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 8170 Jackson Road
  • Suite A
  • Ann Arbor, MI 48103
  • United States

+1 (734) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Strata Oncology’s full profile, request a free trial.

Strata Oncology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 23-May-2018 $26M 0000 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 02-Jun-2016 0000 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Strata Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Strata Oncology Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cancer Genetics Formerly VC-backed Rutherford, NJ 000 000.00 00000000000 000.00
0000000 Formerly VC-backed San Diego, CA 00 00000 000000000 00000
00000000 Venture Capital-Backed Seattle, WA 0000 00000000000 0000
00000000 000000000 Venture Capital-Backed Beijing, China 000.00 00000000000 000.00
0000000000 0000000 Private Equity-Backed Vancouver, Canada 0000000000
To view this company’s complete list of competitors, request access »

Strata Oncology Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Deerfield Management Venture Capital Minority 000 0000 000000 0
Merck Global Health Innovation Fund Corporate Venture Capital Minority 000 0000 000000 0
Pfizer Ventures Corporate Venture Capital Minority 000 0000 000000 0
Renaissance Venture Capital Fund Fund of Funds Minority 000 0000 000000 0
Arboretum Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Strata Oncology Executive Team (7)

Name Title Board
Seat
Contact
Info
Daniel Rhodes Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Matthew Martin Chief Financial Officer
Chris Doughty Director
Scott Tomlins Co-Founder & Laboratory Director
Catherine Sazdanoff Chief Business Officer
You’re viewing 5 of 7 executives. Get the full list »

Strata Oncology Board Members (6)

Name Representing Role Since Contact
Info
Dan Kidle Arboretum Ventures Board Observer 000 0000
Daniel Rhodes Ph.D Strata Oncology Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Jan Garfinkle Arboretum Ventures Board Member 000 0000
Jeffrey Williams Strata Oncology Board Member 000 0000
Nicole Walker Baird Capital Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »